Cited by 1,749Acute Myocardial Infarction ResearchCardiac Imaging and DiagnosticsInflammatory Biomarkers in Disease Prognosis

Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary Syndromes

Open access
Antman, Elliott M., Tanasijevic, Milenko J., Thompson, Bruce, Schactman, Mark, McCabe, Carolyn H., Cannon, Christopher P., Fischer, George A., Fung, Anthony Y. +3 more·1996·New England Journal of Medicine

Abstract

BACKGROUND: In patients with acute coronary syndromes, it is desirable to identify a sensitive serum marker that is closely related to the degree of myocardial damage, provides prognostic information, and can be measured rapidly. We studied the prognostic value of cardiac troponin I levels in patients with unstable angina or non-Q-wave myocardial infarction. METHODS: In a multicenter study, blood specimens from 1404 symptomatic patients were analyzed for cardiac troponin I, a serum marker not detected in the blood of healthy persons. The relation between mortality at 42 days and the level of cardiac troponin I in the specimen obtained on enrollment was determined both before and after adjustment for baseline characteristics. RESULTS: The mortality rate at 42 days was significantly higher in the 573 patients with cardiac troponin I levels of at least 0.4 ng per milliliter (21 deaths, or 3.7 percent) than in the 831 patients with cardiac troponin I levels below 0.4 ng per milliliter (8 deaths, or 1.0 percent; P < 0.001). There were statistically significant increases in mortality with increasing levels of cardiac troponin I (P < 0.001). Each increase of 1 ng per milliliter in the cardiac troponin I level was associated with a significant increase (P = 0.03) in the risk ratio for death after adjustment for the base-line characteristics that were independently predictive of mortality (ST-segment depression and age > or = 65 years). CONCLUSIONS: In patients with acute coronary syndromes, cardiac troponin I levels provide useful prognostic information and permit the early identification of patients with an increased risk of death.

Integrity signals

Registry

Crossref · 10.1056/nejm199610313351802

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Antman, E. M., Tanasijevic, M. J., Thompson, B., Schactman, M., McCabe, C. H., Cannon, C. P., Fischer, G. A., Fung, A. Y., Thompson, C., Wybenga, D., & Braunwald, E.
Affiliations
  • Brigham and Women's Hospital (US)
  • Maryland Medical Research Institute (US)
  • University of British Columbia (CA)
Venue
New England Journal of Medicine
Published
1996-10-31
Volume
335
Issue
18
Pages
1342-1349
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2327567334
Cited by
1,749
References
35
Citations by year
2026: 10 · 2025: 15 · 2024: 18 · 2023: 18 · 2022: 19 · 2021: 24 · 2020: 23 · 2019: 34 · 2018: 26 · 2017: 32 · 2016: 40 · 2015: 51 · 2014: 55 · 2013: 56 · 2012: 58
FWCI
69.44
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01hl042311-03, 5r01hl042428-04)
  • National Heart, Lung, and Blood Institute (R01-HL42311, R01-HL-42428)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
  • Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
Keywords
cardiac troponin I, acute coronary syndrome, mortality prediction, prognostic factors, unstable angina, non-Q-wave myocardial infarction, myocardial injury, ST-segment depression, risk stratification
MeSH terms
Acute Disease, Adult, Aged, Angina, Unstable, Creatine Kinase, Female, Humans, Isoenzymes, Male, Middle Aged, Myocardial Infarction, Prognosis, Retrospective Studies, Risk, Biomarkers, Multivariate Analysis, Odds Ratio, Troponin I

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review